Editas medicine, inc. (EDIT)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15
ASSETS
Current assets:
Cash and cash equivalents

232,850

238,183

104,772

210,605

157,932

134,776

111,701

131,924

217,671

146,630

86,542

144,096

351,552

185,323

199,874

217,650

229,204

143,180

Marketable securities

182,143

218,957

227,844

107,325

184,133

234,179

225,791

212,156

141,150

182,509

209,149

180,699

-

-

-

-

-

-

Accounts receivable

1,832

418

311

0

-

30

43

362

931

679

695

820

945

88

1,122

1,195

1,108

1,019

Prepaid expenses and other current assets

8,281

6,286

6,284

6,298

5,002

5,791

5,018

3,795

3,060

2,381

2,030

2,257

1,289

1,772

2,453

2,373

1,874

786

Total current assets

425,106

463,844

339,211

324,240

347,067

374,776

342,553

348,237

362,812

332,199

298,416

327,872

353,786

187,183

203,449

221,218

232,186

144,985

Property and equipment, net

12,218

10,887

10,075

8,530

7,991

40,232

39,699

39,915

39,551

39,442

39,092

39,358

39,636

40,378

37,072

26,741

15,003

2,130

Right-of-use assets

27,022

28,761

17,681

17,477

18,480

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash and other non-current assets

2,391

5,393

5,392

5,378

5,378

5,378

5,378

5,378

1,619

1,619

1,619

1,619

1,619

1,621

1,632

1,643

1,619

2,248

Total assets

466,737

508,885

372,359

355,625

378,916

420,386

387,630

393,530

403,982

373,260

339,127

368,849

395,041

229,182

242,153

249,602

248,808

149,363

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

10,394

5,843

6,624

3,981

6,557

5,327

5,040

4,661

8,996

4,020

6,976

8,156

15,233

4,640

3,718

5,844

2,909

1,381

Accrued expenses

8,669

22,120

8,138

8,169

5,642

12,813

11,341

11,029

7,767

11,049

8,450

11,160

6,769

17,439

9,492

7,846

7,251

5,456

Notes payable

-

-

-

-

-

-

-

-

-

7,500

-

15,000

15,000

10,000

-

-

-

-

Deferred revenue, current

40,642

23,514

46,019

56,036

23,400

15,712

8,725

7,386

13,323

13,238

13,239

13,239

-

256

-

-

-

-

Operating lease liabilities

5,649

5,804

4,448

3,648

3,519

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31

62

88

Other current liabilities

3,515

2,682

1,558

1,033

1,911

2,048

980

944

908

900

831

1,131

13,285

748

547

-

-

-

Total current liabilities

68,869

59,963

66,787

72,867

41,029

35,900

26,086

24,020

30,994

36,707

29,496

48,686

50,287

33,083

13,757

13,721

10,222

6,925

Operating lease liabilities, net of current portion

21,530

23,277

13,202

13,784

14,859

32,417

32,694

32,944

33,190

33,431

33,667

33,878

33,929

35,096

32,048

22,676

11,649

-

Deferred revenue, net of current portion

141,770

163,207

82,379

75,911

105,865

115,614

104,100

104,929

91,972

94,725

97,851

100,953

104,033

26,000

25,800

25,642

25,479

25,321

Deferred rent, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

353

212

71

-

Warrant to purchase redeemable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

289

Other non-current liabilities

1

1

1

1

1

293

301

305

311

317

325

328

331

396

19

21

24

27

Total liabilities

232,170

246,448

162,369

162,563

161,754

184,224

163,181

162,198

156,467

165,180

161,339

183,845

188,580

94,575

71,977

62,272

47,445

32,562

Commitments and contingencies (see Note 8)

-

-

-

-

-

-

0

0

0

-

0

0

-

0

0

0

0

0

Stockholders' equity
Preferred stock, $0.0001 par value per share: 5,000,000 shares authorized; no shares issued or outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

Common stock, $0.0001 par value per share: 195,000,000 shares authorized; 54,982,399 and 54,533,798 shares issued, and 54,802,399 and 54,355,798 shares outstanding at March 31, 2020 and December 31, 2019, respectively

5

5

5

5

5

5

5

5

4

4

4

4

4

4

4

4

4

-

Additional paid-in capital

820,813

811,546

721,397

671,522

661,852

652,464

615,749

607,311

584,825

514,002

447,468

428,129

423,080

320,129

316,322

312,456

307,448

5,234

Accumulated other comprehensive income

694

107

39

45

29

-29

-82

1

-52

-76

-23

-67

-

-

-

-

-

-

Accumulated deficit

-586,900

-549,221

-511,500

-478,500

-444,724

-416,278

-391,223

-375,985

-337,262

-305,850

-269,661

-243,062

-216,623

-185,526

-146,150

-125,130

-106,089

-88,348

Total stockholders' equity

234,567

262,437

209,990

193,062

217,162

236,162

224,449

231,332

247,515

208,080

177,788

185,004

206,461

134,607

170,176

187,330

201,363

-83,114

Total liabilities and stockholders' equity

466,737

508,885

372,359

355,625

378,916

420,386

387,630

393,530

403,982

373,260

339,127

368,849

395,041

229,182

242,153

249,602

248,808

149,363